{"id":740283,"date":"2023-03-15T08:48:46","date_gmt":"2023-03-15T12:48:46","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-announces-appointment-of-fenel-eloi-to-board-of-directors\/"},"modified":"2023-03-15T08:48:46","modified_gmt":"2023-03-15T12:48:46","slug":"standard-biotools-announces-appointment-of-fenel-eloi-to-board-of-directors","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-announces-appointment-of-fenel-eloi-to-board-of-directors\/","title":{"rendered":"Standard BioTools Announces Appointment of Fenel Eloi to Board of Directors"},"content":{"rendered":"

\nExperienced Life Science Operating Leader Joins Board as Company Enters New Phase
\n<\/h2>\n
\n

SOUTH SAN FRANCISCO, Calif., March 15, 2023 (GLOBE NEWSWIRE) — Standard BioTools Inc.\u00a0(Nasdaq:LAB), driven by a bold purpose \u2013\u00a0Unleashing tools to accelerate breakthroughs in human health<\/em> \u2013 today announced the appointment of Fenel Eloi to its Board of Directors (\u201cBoard\u201d). Eloi will also serve on the Board\u2019s Audit Committee.<\/p>\n

Eloi was most recently the Chief Financial Officer and then Chief Operating Officer of Cell Signaling Technology, Inc., where he oversaw significant growth of the business over a period of 12 years and provided leadership in the transformation of the company to a global operation. Previously, Mr. Eloi was Chief Operating Officer and Chief Financial Officer at Interleukin Genetics. He was also Chief Financial Officer at LifeCell Corporation and Genome Therapeutics Corporation.<\/p>\n

\u201cStandard BioTools is a company undergoing significant transformation and Fenel\u2019s impressive track record operating companies in the life science tools industry will be a great asset as we continue to build a premier life science tools platform company,\u201d said Michael Egholm, President and CEO of Standard BioTools.<\/p>\n

\u201cI am excited to join such a dynamic team building a great company,\u201d said Eloi. \u201cThe mission is clear, the tasks formidable and the team is clearly capable. I am eager to help guide the company as it executes on its journey.\u201d<\/p>\n

Concurrent with the appointment of Mr. Eloi, Bill Colston will retire from Standard BioTools’ Board and the Compensation Committee of the Board.<\/p>\n

\u201cOn behalf of the entire Board, I thank Bill for his strong contributions to Standard BioTools,\u201d said Carlos Paya, Chairman of the Board.<\/p>\n

\n About Standard BioTools Inc.<\/strong>\u00a0<\/p>\n

Standard BioTools Inc. (Nasdaq:LAB), previously known as Fluidigm Corporation, is driven by a bold purpose \u2013\u00a0Unleashing tools to accelerate breakthroughs in human health<\/em>.\u00a0Standard BioTools has an established portfolio of essential, standardized next-generation technologies that help biomedical researchers develop medicines faster and better. As a leading solutions provider, the company provides reliable and repeatable insights in health and disease using its proprietary mass cytometry and microfluidics technologies, which help transform scientific discoveries into better patient outcomes. Standard BioTools works with leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy. Learn more at standardbio.com or connect with us on Twitter\u00ae<\/a>, Facebook\u00ae<\/a>, LinkedIn<\/a>, and YouTube\u2122<\/a>. Standard BioTools, the Standard BioTools logo, Fluidigm, the Fluidigm logo and \u201cUnleashing tools to accelerate breakthroughs in human health\u201d are trademarks and\/or registered trademarks of\u00a0Standard BioTools Inc.\u00a0or its affiliates in\u00a0the United States\u00a0and\/or other countries. All other trademarks are the sole property of their respective owners. Standard BioTools\u00a0products are provided for\u00a0Research Use Only<\/strong>. Not for use in diagnostic procedures.<\/p>\n

\n Available Information<\/strong>\u00a0<\/p>\n

Standard BioTools\u00a0uses its website (standardbio.com<\/a>), investor site (investors.standardbio.com<\/a>), corporate Twitter account (@Standard_BioT<\/a>), Facebook page (facebook.com\/StandardBioT),<\/a> and LinkedIn page (linkedin.com\/company\/standard-biotools<\/a>) as channels of distribution of information about its products, its planned financial and other announcements, its attendance at upcoming investor and industry conferences, and other matters. Such information may be deemed material information, and\u00a0Standard BioTools\u00a0may use these channels to comply with its disclosure obligations under Regulation FD. Therefore, investors should monitor Standard BioTools\u2019 website and its social media accounts in addition to following its press releases,\u00a0SEC\u00a0filings, public conference calls, and webcasts.<\/p>\n

\n Investors Contacts:<\/strong>\u00a0<\/p>\n

Scott R. Greenstone, CFA
ir@standardbio.com<\/u><\/a>\u00a0<\/p>\n

Peter DeNardo\u00a0
415 389 6400\u00a0
ir@standardbio.com<\/u><\/a>\u00a0<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Experienced Life Science Operating Leader Joins Board as Company Enters New Phase SOUTH SAN FRANCISCO, Calif., March 15, 2023 (GLOBE NEWSWIRE) — Standard BioTools Inc.\u00a0(Nasdaq:LAB), driven by a bold purpose \u2013\u00a0Unleashing tools to accelerate breakthroughs in human health \u2013 today announced the appointment of Fenel Eloi to its Board of Directors (\u201cBoard\u201d). Eloi will also serve on the Board\u2019s Audit Committee. Eloi was most recently the Chief Financial Officer and then Chief Operating Officer of Cell Signaling Technology, Inc., where he oversaw significant growth of the business over a period of 12 years and provided leadership in the transformation of the company to a global operation. Previously, Mr. Eloi was Chief Operating Officer and Chief Financial Officer at Interleukin Genetics. … <\/p>\n

Continue reading “Standard BioTools Announces Appointment of Fenel Eloi to Board of Directors”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-740283","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nStandard BioTools Announces Appointment of Fenel Eloi to Board of Directors - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-announces-appointment-of-fenel-eloi-to-board-of-directors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Standard BioTools Announces Appointment of Fenel Eloi to Board of Directors - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Experienced Life Science Operating Leader Joins Board as Company Enters New Phase SOUTH SAN FRANCISCO, Calif., March 15, 2023 (GLOBE NEWSWIRE) — Standard BioTools Inc.\u00a0(Nasdaq:LAB), driven by a bold purpose \u2013\u00a0Unleashing tools to accelerate breakthroughs in human health \u2013 today announced the appointment of Fenel Eloi to its Board of Directors (\u201cBoard\u201d). Eloi will also serve on the Board\u2019s Audit Committee. Eloi was most recently the Chief Financial Officer and then Chief Operating Officer of Cell Signaling Technology, Inc., where he oversaw significant growth of the business over a period of 12 years and provided leadership in the transformation of the company to a global operation. Previously, Mr. Eloi was Chief Operating Officer and Chief Financial Officer at Interleukin Genetics. … Continue reading "Standard BioTools Announces Appointment of Fenel Eloi to Board of Directors"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-announces-appointment-of-fenel-eloi-to-board-of-directors\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-15T12:48:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4ODQ3OSM1NDYyMzA5IzIwMDM4MTg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-announces-appointment-of-fenel-eloi-to-board-of-directors\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-announces-appointment-of-fenel-eloi-to-board-of-directors\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Standard BioTools Announces Appointment of Fenel Eloi to Board of Directors\",\"datePublished\":\"2023-03-15T12:48:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-announces-appointment-of-fenel-eloi-to-board-of-directors\\\/\"},\"wordCount\":593,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-announces-appointment-of-fenel-eloi-to-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc4ODQ3OSM1NDYyMzA5IzIwMDM4MTg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-announces-appointment-of-fenel-eloi-to-board-of-directors\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-announces-appointment-of-fenel-eloi-to-board-of-directors\\\/\",\"name\":\"Standard BioTools Announces Appointment of Fenel Eloi to Board of Directors - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-announces-appointment-of-fenel-eloi-to-board-of-directors\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-announces-appointment-of-fenel-eloi-to-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc4ODQ3OSM1NDYyMzA5IzIwMDM4MTg=\",\"datePublished\":\"2023-03-15T12:48:46+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-announces-appointment-of-fenel-eloi-to-board-of-directors\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-announces-appointment-of-fenel-eloi-to-board-of-directors\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-announces-appointment-of-fenel-eloi-to-board-of-directors\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc4ODQ3OSM1NDYyMzA5IzIwMDM4MTg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc4ODQ3OSM1NDYyMzA5IzIwMDM4MTg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-announces-appointment-of-fenel-eloi-to-board-of-directors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Standard BioTools Announces Appointment of Fenel Eloi to Board of Directors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Standard BioTools Announces Appointment of Fenel Eloi to Board of Directors - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-announces-appointment-of-fenel-eloi-to-board-of-directors\/","og_locale":"en_US","og_type":"article","og_title":"Standard BioTools Announces Appointment of Fenel Eloi to Board of Directors - Market Newsdesk","og_description":"Experienced Life Science Operating Leader Joins Board as Company Enters New Phase SOUTH SAN FRANCISCO, Calif., March 15, 2023 (GLOBE NEWSWIRE) — Standard BioTools Inc.\u00a0(Nasdaq:LAB), driven by a bold purpose \u2013\u00a0Unleashing tools to accelerate breakthroughs in human health \u2013 today announced the appointment of Fenel Eloi to its Board of Directors (\u201cBoard\u201d). Eloi will also serve on the Board\u2019s Audit Committee. Eloi was most recently the Chief Financial Officer and then Chief Operating Officer of Cell Signaling Technology, Inc., where he oversaw significant growth of the business over a period of 12 years and provided leadership in the transformation of the company to a global operation. Previously, Mr. Eloi was Chief Operating Officer and Chief Financial Officer at Interleukin Genetics. … Continue reading \"Standard BioTools Announces Appointment of Fenel Eloi to Board of Directors\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-announces-appointment-of-fenel-eloi-to-board-of-directors\/","og_site_name":"Market Newsdesk","article_published_time":"2023-03-15T12:48:46+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4ODQ3OSM1NDYyMzA5IzIwMDM4MTg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-announces-appointment-of-fenel-eloi-to-board-of-directors\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-announces-appointment-of-fenel-eloi-to-board-of-directors\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Standard BioTools Announces Appointment of Fenel Eloi to Board of Directors","datePublished":"2023-03-15T12:48:46+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-announces-appointment-of-fenel-eloi-to-board-of-directors\/"},"wordCount":593,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-announces-appointment-of-fenel-eloi-to-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4ODQ3OSM1NDYyMzA5IzIwMDM4MTg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-announces-appointment-of-fenel-eloi-to-board-of-directors\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-announces-appointment-of-fenel-eloi-to-board-of-directors\/","name":"Standard BioTools Announces Appointment of Fenel Eloi to Board of Directors - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-announces-appointment-of-fenel-eloi-to-board-of-directors\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-announces-appointment-of-fenel-eloi-to-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4ODQ3OSM1NDYyMzA5IzIwMDM4MTg=","datePublished":"2023-03-15T12:48:46+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-announces-appointment-of-fenel-eloi-to-board-of-directors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-announces-appointment-of-fenel-eloi-to-board-of-directors\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-announces-appointment-of-fenel-eloi-to-board-of-directors\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4ODQ3OSM1NDYyMzA5IzIwMDM4MTg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4ODQ3OSM1NDYyMzA5IzIwMDM4MTg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-announces-appointment-of-fenel-eloi-to-board-of-directors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Standard BioTools Announces Appointment of Fenel Eloi to Board of Directors"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/740283","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=740283"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/740283\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=740283"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=740283"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=740283"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}